18 January 2017
News and Views
Links and Services
A study published ahead of print in the Alimentary Pharmacology & Therapeutics reports an increased risk of herpes zoster among patients with inflammatory bowel disease.
Patients with inflammatory bowel disease on certain immunosuppressants have increased herpes zost
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors